Elevance: 3 Key Takeaways for Long-Term Investors

Elevance Health raised its 2026 earnings baseline to at least $26.75 per share, driven by favorable claims in Individual ACA plans and improved full-year outlook. The company's Carelon healthcare services unit reduced avoidable hospital admissions by 15% through targeted cancer care programs, while integrated pharmacy and medical coverage is generating member savings of up to $100 per month. Management expects broad-based operating improvements to continue into future periods, positioning the company for sustainable long-term earnings growth.